SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
22nd Century Group, Inc. Files Investigational New Drug Application and Fast Track Request for X-22; Phase II-B Clinical Trial to Commence Immediately Upon FDA Clearance